McClung MR - Search Results

1

Denosumab in postmenopausal women with low bone mineral density.

McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ; AMG 162 Bone Loss Study Group. McClung MR, et al. N Engl J Med. 2006 Feb 23;354(8):821-31. doi: 10.1056/NEJMoa044459. N Engl J Med. 2006. PMID: 16495394 Free article. Clinical Trial.

2

Enhanced precision with dual-energy X-ray absorptiometry.

Mazess R, Chesnut CH 3rd, McClung M, Genant H. Mazess R, et al. Calcif Tissue Int. 1992 Jul;51(1):14-7. doi: 10.1007/BF00296209. Calcif Tissue Int. 1992. PMID: 1393769

3

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling.

Chesnut CH 3rd, McClung MR, Ensrud KE, Bell NH, Genant HK, Harris ST, Singer FR, Stock JL, Yood RA, Delmas PD, et al. Chesnut CH 3rd, et al. Among authors: mcclung mr. Am J Med. 1995 Aug;99(2):144-52. doi: 10.1016/s0002-9343(99)80134-x. Am J Med. 1995. PMID: 7625419 Clinical Trial.

4

Use of bone densitometry results for decisions about therapy for osteoporosis.

Ettnger B, Miller P, McClung MR. Ettnger B, et al. Among authors: mcclung mr. Ann Intern Med. 1996 Oct 1;125(7):623. doi: 10.7326/0003-4819-125-7-199610010-00021. Ann Intern Med. 1996. PMID: 8815769 No abstract available.

5

Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.

McClung MR. McClung MR. Bone. 1996 Nov;19(5 Suppl):195S-198S. doi: 10.1016/s8756-3282(96)90165-9. Bone. 1996. PMID: 8922662 Review.

6

Prediction of fracture risk. I: Bone density.

Miller PD, McClung M. Miller PD, et al. Am J Med Sci. 1996 Dec;312(6):257-9. doi: 10.1097/00000441-199612000-00003. Am J Med Sci. 1996. PMID: 8969614 Review.

7

Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women.

Stock JL, Bell NH, Chesnut CH 3rd, Ensrud KE, Genant HK, Harris ST, McClung MR, Singer FR, Yood RA, Pryor-Tillotson S, Wei L, Santora AC 2nd. Stock JL, et al. Among authors: mcclung mr. Am J Med. 1997 Oct;103(4):291-7. doi: 10.1016/s0002-9343(97)00130-7. Am J Med. 1997. PMID: 9382121 Clinical Trial.

8

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ. Hosking D, et al. N Engl J Med. 1998 Feb 19;338(8):485-92. doi: 10.1056/NEJM199802193380801. N Engl J Med. 1998. PMID: 9443925 Free article. Clinical Trial.

9

Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study Group.

McClung M, Clemmesen B, Daifotis A, Gilchrist NL, Eisman J, Weinstein RS, Fuleihan G el-H, Reda C, Yates AJ, Ravn P. McClung M, et al. Ann Intern Med. 1998 Feb 15;128(4):253-61. doi: 10.7326/0003-4819-128-4-199802150-00001. Ann Intern Med. 1998. PMID: 9471927 Clinical Trial.

10

Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.

Siris ES, Chines AA, Altman RD, Brown JP, Johnston CC Jr, Lang R, McClung MR, Mallette LE, Miller PD, Ryan WG, Singer FR, Tucci JR, Eusebio RA, Bekker PJ. Siris ES, et al. Among authors: mcclung mr. J Bone Miner Res. 1998 Jun;13(6):1032-8. doi: 10.1359/jbmr.1998.13.6.1032. J Bone Miner Res. 1998. PMID: 9626635 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters